Tumor Antigens
Creative Biolabs supports cancer vaccine research by offering a comprehensive portfolio of high-quality Tumor Antigens, designed to drive innovation in immunotherapy development. Our tumor antigen products encompass a diverse range of targets, enabling researchers to address various cancer types by leveraging these antigens as immunogens for vaccine design or sensitive markers for diagnostic assays. Each antigen is produced with rigorous quality control, ensuring high immunogenicity and specificity to facilitate robust immune response induction. With sufficient inventory and global fast delivery, we ensure timely support for both academic and industrial projects, while quantity discounts make our solutions cost-effective for large-scale research.
Ready to accelerate your cancer vaccine research? Contact us today to explore our tumor antigen offerings and discuss how our tailored solutions can advance your project. Our experts are available to provide personalized quotes, feasibility assessments, and collaborative support at every stage. Don’t miss the opportunity to leverage our cutting-edge technologies and industry expertise—reach out now to unlock new possibilities in cancer immunotherapy!
| CAT | Product Name | Source | Product Overview | Target | Type | Datasheet | Size | Price |
|---|---|---|---|---|---|---|---|---|
| VAng-4469Lsx | Recombinant Human CD19 Protein (aa 20-291) | Cell Free Expression | Recombinant Human CD19 protein, expressed in Cell Free Expression systems. (Uniprot ID: P15391) | CD19 | Tumor Antigens |  |
100 µg | Inquiry |
All of our products can only be used for research purposes. These vaccine ingredients CANNOT be used directly on humans or animals.
